Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for ATORVASTATIN

Ingredient

ATORVASTATIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-ATORVASTATIN	40MG	TABLET	Resolved	2019-08-22	2020-01-09	92140
TEVA-ATORVASTATIN	40MG	TABLET	Resolved	2024-09-05	2024-09-19	236813
TEVA-ATORVASTATIN	40MG	TABLET	Resolved	2024-07-18	2024-11-14	233267
TEVA-ATORVASTATIN	40MG	TABLET	Resolved	2024-06-07	2024-07-26	229954
TEVA-ATORVASTATIN	40MG	TABLET	Resolved	2023-11-30	2024-01-11	211992
TEVA-ATORVASTATIN	40MG	TABLET	Resolved	2023-11-30	2023-12-07	211988
TEVA-ATORVASTATIN	40MG	TABLET	Resolved	2022-12-08	2023-01-12	177517
TEVA-ATORVASTATIN	40MG	TABLET	Resolved	2022-12-08	2023-02-02	177514
TEVA-ATORVASTATIN	40MG	TABLET	Resolved	2022-10-28	2023-01-12	173061
TEVA-ATORVASTATIN	40MG	TABLET	Resolved	2022-06-03	2022-08-19	161949

Previous
1
…
25
26
27
28
Next

Showing 261 to 270 of 276

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-ATORVASTATIN	80MG	TABLET	Reversed	2025-05-28	2025-06-04	258655

Previous
1
…
4
5
6

Showing 51 to 51 of 51